miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo.
about
Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and diseaseEpigenetics meets radiation biology as a new approach in cancer treatmentUnraveling 50-Year-Old Clues Linking Neurodegeneration and Cancer to Cycad Toxins: Are microRNAs Common Mediators?MiR-200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1.Inhibition of nucleoporin member Nup214 expression by miR-133b perturbs mitotic timing and leads to cell death.TAp63 suppress metastasis via miR-133b in colon cancer cells.MiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis.microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers.Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth.microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1.The role of microRNA-133b and its target gene FSCN1 in gastric cancer.Cancer and neurodegenerative disorders: pathogenic convergence through microRNA regulation.MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis.Serum miR-210 Contributes to Tumor Detection, Stage Prediction and Dynamic Surveillance in Patients with Bladder Cancer.Helicobacter Pylori Promote B7-H1 Expression by Suppressing miR-152 and miR-200b in Gastric Cancer CellsMorphine and microRNA Activity: Is There a Relation with Addiction?MicroRNA manipulation in colorectal cancer cells: from laboratory to clinical application.miR-133b Regulation of Connective Tissue Growth Factor: A Novel Mechanism in Liver PathologyGastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma.Downregulation of miR-133b predict progression and poor prognosis in patients with urothelial carcinoma of bladderMicroRNA Expression Profile on Solid Subtype of Invasive Lung Adenocarcinoma Reveals a Panel of Four miRNAs to Be Associated with Poor Prognosis in Chinese Patients.Transcriptome-wide analysis of compression-induced microRNA expression alteration in breast cancer for mining therapeutic targetsmiR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of CXCR4 expressionTissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers.The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials.Roles of microRNAs during prostatic tumorigenesis and tumor progression.Role of met axis in head and neck cancer.Circulating miRNAs as biomarkers for neurodegenerative disorders.MicroRNAs as potential drug targets for therapeutic intervention in colorectal cancer.Targeting c-Met in Cancer by MicroRNAs: Potential Therapeutic Applications in Hepatocellular Carcinoma.miRNA profiling in gastrointestinal stromal tumors: implication as diagnostic and prognostic markers.miR-154 suppresses colorectal cancer cell growth and motility by targeting TLR2.MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells.MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways.miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer.miR-133b, a particular member of myomiRs, coming into playing its unique pathological role in human cancermiR-133b down-regulates ABCC1 and enhances the sensitivity of CRC to anti-tumor drugs.miR-133b inhibits glioma cell proliferation and invasion by targeting Sirt1.DNA methylation is involved in the aberrant expression of miR-133b in colorectal cancer cells.
P2860
Q26795757-026EC0B9-9E7C-45F8-A318-201544EE9B94Q27014984-96FF0940-42E6-4646-A001-BACF30E8BB56Q28389159-5BC2F4DC-9B59-4EA4-A375-7DD266B9466EQ30487604-A73C6B28-E7DC-42F3-94ED-404651D63B22Q30620884-C99B1C68-AF76-4B35-AD55-474246A8DD7DQ33555190-045F6E80-7646-47FB-8AE7-B8F4C5CD4434Q34245074-C43FB2D7-023E-4F35-8B80-D6E9D93B1FB0Q34252329-81BE334B-7CEB-408D-9E07-481676057823Q34275817-6E2075B0-45EC-4486-8EC4-C9E394BCA244Q34312916-C1B6E9DF-8B25-4DF4-AD28-31D2780EDF5AQ34545805-ED4553EE-9DFA-49EC-9A02-69E6D47A1C08Q34748529-D44BD7F0-9CA4-4D97-AA2E-06F7E29B5D37Q35013343-028BA0B7-0E1E-4DD7-AEBF-64573568388FQ35082529-282A038C-1CA8-47D4-A2C4-9A797AC74414Q35740045-6B809A26-0917-4316-9B95-A50644CA6AA9Q36240460-979E5555-B555-4D09-AF03-DC2F949FC484Q36386234-0A60BEE0-9CD0-4E20-81F9-8CDEA8AE296DQ36517482-C7FEE35C-9C26-4E5D-AD80-13906F325DC5Q36885711-87B227E2-0103-4296-B457-6F0CCE10F41CQ37063944-CE583207-2DC3-4DAE-AC7F-54F9C89CD16DQ37148931-655C655C-B456-462B-9A8C-35D116EC1581Q37290532-509CC607-856F-4CBF-9781-95B99D9E8904Q37317295-262D4767-79F8-4830-8AA2-37CF1DAC2AC5Q37400908-FB6ADA3D-B158-4595-80A7-6A54B925F33EQ37822465-1B676649-C940-46BB-BB5E-C81CA02FD2E1Q37950469-EE4E90FE-65E6-4B32-9832-E0261292F25FQ38086009-CE3ACB0F-E909-47AA-B9A5-2EA8D14A8133Q38167258-387E96AC-9344-49DA-83E0-5942100ACFD9Q38214427-3C559019-3BA1-44D2-92FD-AABAD6D261E4Q38550157-AC24A8CA-47E9-49C0-84BA-DE766B18F08BQ38585471-E1B0670A-2237-4D05-B315-35321BBF68D6Q38602174-01382373-48EF-4511-9833-29AF0E4746EDQ39062255-24F08052-44BB-4863-AC21-D782497C7CA6Q39160607-BEB4ABAF-31CE-4003-BA55-DA50269EE4FEQ39426030-4727BC36-FF7D-4361-B605-7BC20AA750ADQ41412761-7E2DE0A6-8C10-45CA-BA56-AA9C77989CD1Q41473012-6CE85EA7-1ADD-4BBD-830E-3E03CCBF4506Q41593000-A711A671-BD2C-4B92-968D-0B8873467B13Q41667363-0EE352FD-1C44-42EA-8B86-89F1E93AD50EQ42365381-D53C95FC-5F81-4ABC-A5B6-1621767DF01B
P2860
miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
miR-133b regulates the MET pro ...... er cells in vitro and in vivo.
@en
miR-133b regulates the MET pro ...... er cells in vitro and in vivo.
@nl
type
label
miR-133b regulates the MET pro ...... er cells in vitro and in vivo.
@en
miR-133b regulates the MET pro ...... er cells in vitro and in vivo.
@nl
prefLabel
miR-133b regulates the MET pro ...... er cells in vitro and in vivo.
@en
miR-133b regulates the MET pro ...... er cells in vitro and in vivo.
@nl
P2093
P356
P1476
miR-133b regulates the MET pro ...... er cells in vitro and in vivo.
@en
P2093
P304
P356
10.4161/CBT.10.2.12186
P577
2010-07-27T00:00:00Z